Skip to content
Homepage link
About
Overview Our Story Q&A Our Team Board of Directors Medical & Scientific Advisors
Programs
Overview Pipeline Oncology Inflammatory Diseases
Clinical Trials
Newsroom
Contact
  1. Home
  2. | About
  3. | Our Team
Our Team Board of Directors Medical and Scientific Advisors
Robert D Ladner, PhD

Robert D Ladner, PhD

Chief Executive Officer & Founder

Karl Mulligan, PhD

Karl Mulligan, PhD

Chief Operating Officer & Co-Founder

Richard Milliken, CA

Richard Milliken, CA

Chairman of the Board & Chief Financial Officer

Peter M. Wilson, PhD

Peter M. Wilson, PhD

Director of Science & Drug Development

Melissa LaBonte Wilson, PhD

Melissa LaBonte Wilson, PhD

Scientific Advisor

Glen Clack, MBBS, MD, FFPM

Glen Clack, MBBS, MD, FFPM

Chief Medical Officer

Tess Barker, PhD

Tess Barker, PhD

Program Lead (Consulting)

Kylie A. McLaughlin, PhD

Kylie A. McLaughlin, PhD

Associate Principal Scientist

Declan Doherty, PhD

Declan Doherty, PhD

Senior Scientist

Lauren Cairns, PhD

Lauren Cairns, PhD

Senior Scientist

Rebecca Eakin, MSc

Rebecca Eakin, MSc

Research Scientist

Jill King

Jill King

Office Administrator

Joan Lynch

Joan Lynch

Chief of Staff & Communication Lead (Consulting)

Gregory Keever, JD

Gregory Keever, JD

Legal Advisor

Homepage link
About
Our Story
Our Team
Board of Directors
Medical and Scientific Advisors
Programs
Pipeline
Oncology
Inflamatory Diseases
Useful Links
Clinical Trials
Newsroom
Contact
Legal
Cookie Policy
Privacy Policy

© 2026 CV6 Therapeutics (NI) Ltd. All rights reserved.

Website by
PBD

Disclaimer: CV6-168 and CV6-1271 are investigational therapies that have not been approved for use outside clinical studies by the MHRA, FDA, or other regulatory authorities.